And then we'll get into the 2nd quarter in late October 23andMe reconstituted our board of directors with the appointment of three new independent directors. We are pleased that these accomplished and ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...

23andMe's CEO called the decision to lay off 200 employees ... The suffering company faced another blow in September when its board of directors resigned. The board’s seven members quit after Wojcicki ...

In addition to workforce reductions, 23andMe has also decided to discontinue its therapeutic ... The situation worsened in ...

Back in September, all of 23andMe’s independent directors also resigned from its board — in a rare move that followed ...

Sales for the Atlanta-based company improved 6.6 percent to $40.22 billion, topping the $39.31 billion that analysts ...

23andMe, a popular South San Francisco-based genetic testing company, is laying off 40% of its workers after struggling with ...

Me is laying off 40% of its workforce right before the holiday season - The restructuring arrives during a period of turmoil ...

Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...

Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...